Your browser doesn't support javascript.
loading
Neuroimaging evidence for structural correlates in adolescents resilient to polysubstance use: A five-year follow-up study.
Filippi, Irina; Galinowski, André; Lemaître, Hervé; Massot, Christian; Zille, Pascal; Frère, Pauline; Miranda-Marcos, Rubén; Trichard, Christian; Guldner, Stella; Vulser, Hélène; Paillère-Martinot, Marie-Laure; Quinlan, Erin Burke; Desrivieres, Sylvane; Gowland, Penny; Bokde, Arun; Garavan, Hugh; Heinz, Andreas; Walter, Henrik; Daedelow, Laura; Büchel, Christian; Bromberg, Uli; Conrod, Patricia J; Flor, Herta; Banaschewski, Tobias; Nees, Frauke; Heintz, Stefan; Smolka, Michael; Vetter, Nora C; Papadopoulos-Orfanos, Dimitri; Whelan, Robert; Poustka, Louise; Paus, Tomas; Schumann, Gunter; Artiges, Eric; Martinot, Jean-Luc.
Afiliação
  • Filippi I; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Galinowski A; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Lemaître H; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Massot C; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Zille P; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Frère P; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Miranda-Marcos R; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France; Hôpitaux de Paris, Department of Psychiatry and Addictology, Paul Br
  • Trichard C; Etablissement Public de Santé Barthélémy Durand, Department of Psychiatry, Étampes, France.
  • Guldner S; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Vulser H; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Paillère-Martinot ML; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France.
  • Quinlan EB; MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Desrivieres S; MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Gowland P; School of Physics and Astronomy, Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom.
  • Bokde A; Trinity College, Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Dublin, Ireland.
  • Garavan H; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA.
  • Heinz A; Department of Psychiatry and Psychotherapy, Charite University Hospital Berlin, Berlin, Germany.
  • Walter H; Department of Psychiatry and Psychotherapy, Charite University Hospital Berlin, Berlin, Germany.
  • Daedelow L; Department of Psychiatry and Psychotherapy, Charite University Hospital Berlin, Berlin, Germany.
  • Büchel C; Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bromberg U; Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Conrod PJ; Sainte Justine Hospital, Department of Psychiatry, Montreal University, Montréal, Québec, Canada.
  • Flor H; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Banaschewski T; Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute for Mental Health, Heidelberg University, Mannheim, Germany.
  • Nees F; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Heintz S; Central Institute of Mental Health, Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Smolka M; Technische Universität Dresden, Department of Psychiatry, Dresden, Germany.
  • Vetter NC; Technische Universität Dresden, Department of Psychiatry, Dresden, Germany.
  • Papadopoulos-Orfanos D; Commissariat a l'Energie Atomique et aux Energies Alternatives Centre de Saclay, Neurospin, Saclay, France.
  • Whelan R; School of Psychology and Global Brain Health Institute, University College Dublin, Dublin, Ireland.
  • Poustka L; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
  • Paus T; University of Toronto, Rotman Research Institute, Toronto, Ontario, Canada.
  • Schumann G; MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Artiges E; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France; GH Nord Essonne, Service de Psychiatrie 91G16, Orsay, France.
  • Martinot JL; INSERM U1299 Developmental Trajectories & Psychiatry, Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CNRS, Centre Borelli, Digiteo Labs, Avenue des Sciences, Bâtiment 660 Claude Shannon, Gif-sur-Yvette, France; Centre de Neuro-Imagerie de Recherche, Institut du Cerveau et de la
Eur Neuropsychopharmacol ; 49: 11-22, 2021 08.
Article em En | MEDLINE | ID: mdl-33770525
Early initiation of polysubstance use (PSU) is a strong predictor of subsequent addiction, however scarce individuals present resilience capacity. This neuroimaging study aimed to investigate structural correlates associated with cessation or reduction of PSU and determine the extent to which brain structural features accounted for this resilient outcome. Participants from a European community-based cohort self-reported their alcohol, tobacco and cannabis use frequency at ages 14, 16 and 19 and had neuroimaging sessions at ages 14 and 19. We included three groups in the study: the resilient-to-PSU participants showed PSU at 16 and/or 14 but no more at 19 (n = 18), the enduring polysubstance users at 19 displayed PSU continuation from 14 or 16 (n = 193) and the controls were abstinent or low drinking participants (n = 460). We conducted between-group comparisons of grey matter volumes on whole brain using voxel-based morphometry and regional fractional anisotropy using tract-based spatial statistics. Random-forests machine-learning approach generated individual-level PSU-behavior predictions based on personality and neuroimaging features. Adolescents resilient to PSU showed significant larger grey matter volumes in the bilateral cingulate gyrus compared with enduring polysubstance users and controls at ages 19 and 14 (p<0.05 corrected) but no difference in fractional anisotropy. The larger cingulate volumes and personality trait "openness to experience" were the best precursors of resilience to PSU. Early in adolescence, a larger cingulate gyrus differentiated adolescents resilient to PSU, and this feature was critical in predicting this outcome. This study encourages further research into the neurobiological bases of resilience to addictive behaviors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Alcoolismo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Alcoolismo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article